BIOTIE THERAPIES CORP SPONSORED ADR
BITI
BITI was delisted on the 10th of June, 2016.
19 hedge funds and large institutions have $77.5M invested in BIOTIE THERAPIES CORP SPONSORED ADR in 2015 Q2 according to their latest regulatory filings, with 19 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$19.3M |
| 2 |
BG
Baupost Group
Boston,
Massachusetts
|
+$18.2M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$5.94M |
| 4 |
O
OrbiMed
New York
|
+$5.61M |
| 5 |
VVM
Versant Venture Management
San Francisco,
California
|
+$5.61M |
Top Sellers
BITI Hedge Fund Activity: Q2 2015 in Review
19 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in BIOTIE THERAPIES CORP SPONSORED ADR (BITI) for Q2 2015, worth a combined $77.5M.
Buyers outnumbered sellers: 19 funds opened new BITI positions and 0 closed out — a net gain of 19 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $19.3M.
- 19 institutional investors held BIOTIE THERAPIES CORP SPONSORED ADR (BITI) as of Q2 2015, up from 0 in Q1 2015.
- Funds reported $77.5M of BIOTIE THERAPIES CORP SPONSORED ADR stock for Q2 2015.
- 19 funds opened new BIOTIE THERAPIES CORP SPONSORED ADR positions in Q2 2015 and 0 closed out, a net change of +19 holders.
- The largest BIOTIE THERAPIES CORP SPONSORED ADR buyer in Q2 2015 was Fidelity Investments, an estimated $19.3M added.
Based on aggregated 13F filings for Q2 2015.